The Discounted Cash Flow (DCF) valuation of Vicore Pharma Holding AB (VICO.ST) is 2.74 SEK. With the latest stock price at 7.85 SEK, the upside of Vicore Pharma Holding AB based on DCF is -65.1%.
Based on the latest price of 7.85 SEK and our DCF valuation, Vicore Pharma Holding AB (VICO.ST) is a sell. selling VICO.ST stocks now will result in a potential gain of 65.1%.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 7.9% | 7.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 2.33 - 2.83 | 2.74 |
| Upside | -70.3% - -64.0% | -65.1% |